Cargando…
Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer
In a personalized treatment designed for a patient with pancreatic cancer resistant to other treatments, the success of Mitomycin C (MMC) has been highlighted. This was revealed in a murine xenograft tumor model encompassing pancreatic adenocarcinoma cells extracted from the patient. The patient was...
Autores principales: | Navarrete, Alicia, Armitage, Emily G, Musteanu, Monica, García, Antonia, Mastrangelo, Annalaura, Bujak, Renata, López-Casas, Pedro P, Hidalgo, Manuel, Barbas, Coral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186447/ https://www.ncbi.nlm.nih.gov/pubmed/25505613 http://dx.doi.org/10.1002/prp2.67 |
Ejemplares similares
-
Altered Metabolic and Stemness Capacity of Adipose Tissue-Derived Stem Cells from Obese Mouse and Human
por: Pérez, Laura M., et al.
Publicado: (2015) -
Metabolomic-Based Methods in Diagnosis and Monitoring Infection Progression
por: Fernández-García, Miguel, et al.
Publicado: (2018) -
Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression
por: Xie, Tao, et al.
Publicado: (2015) -
Metabolomics and neuroanatomical evaluation of post-mortem changes in the hippocampus
por: Gonzalez-Riano, Carolina, et al.
Publicado: (2017) -
Metabolomic Fingerprinting in the Comprehensive Study of Liver Changes Associated with Onion Supplementation in Hypercholesterolemic Wistar Rats
por: González-Peña, Diana, et al.
Publicado: (2017)